Coversyl Arginine

Coversyl Arginine Dosage/Direction for Use

perindopril

Manufacturer:

Servier

Distributor:

DKSH
Full Prescribing Info
Dosage/Direction for Use
Recommended dose: For arterial hypertension: The recommended dosage is 5 mg daily in the morning. This may be increased to 10 mg daily in a single dose, if necessary, after 1 month of treatment.
In the elderly patient, treatment should be started with 2.5 mg daily in the morning and this may be increased to 5 mg daily, if necessary, after 1 month of treatment.
In case of renal failure, the dosage of perindopril must be adjusted according to the degree of renal failure.
In these patients, normal medical practice involves periodic determination of serum potassium and creatinine levels.
For congestive heart failure: The treatment should be started under close medical supervision. The recommended initial dose is 2.5 mg daily in the morning. This may be increased to 5 mg daily once blood pressure acceptability has been demonstrated.
For prevention of stroke recurrence: In patients with a history of cerebrovascular disease, COVERSYL ARGININE should be introduced at a dose of 2.5 mg daily for two weeks, then increased to 5 mg daily for a further 2 weeks before introducing indapamide.
Treatment can be initiated at any time from 2 weeks up to several years after the initial stroke episode.
For reduction of risk of cardiovascular event: In patients with stable coronary artery disease, COVERSYL ARGININE should be introduced at a dose of 5 mg once daily for two weeks, then increased to 10 mg once daily, depending on renal function.
Elderly patients should receive a dose of 2.5 mg once daily for one week, then 5 mg once daily the next week, before increasing the dose up to 10 mg once daily depending on renal function.
Mode of Administration: For adults only: Oral route, before meal.
In all cases strictly comply with the physician's prescription.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in